The round was closed with an investment from the European Circular Bioeconomy Fund (ECBF) and the two existing investors, Sofinnova Partners and Novo Seeds
Proportion of the eligible population yet to receive a COVID-19 vaccine is comparatively small
.jpg)
Evonik's six innovation growth fields are: Sustainable nutrition, healthcare solutions, advanced food ingredients, membranes, cosmetic solutions, and additive manufacturing
The FDA informed Astellas that it did not have sufficient information to assess the risks to subjects
Most recently, she served as chief human resources officer at Vyripharm Enterprises.
COR803 is a novel small molecule 3CLpro inhibitor discovered and developed by Cortexyme based on its expertise in cysteine protease inhibition.
It is only the second healthcare provider in the world to attain the Stage 6 DIAM certification.
With $120m jointly invested in the newly-formed initiative, and with other strategic investors expected to join, the venture will develop an alternative, plant-based ingredient using biotechnology
Revenues from operations for the full year ended March 31, 2022 stood at Rs. 590.05 crore as compared to Rs. 449.82 crore in FY21
63-year old woman gets rare Transcatheter Tricuspid Valve Replacement (TTVR)
Subscribe To Our Newsletter & Stay Updated
